Zhang Xuan, Guseinov Abdul-Akim, Jenkins Laura, Valentini Alice, Marsango Sara, Schultz-Knudsen Katrine, Ulven Trond, Rexen Ulven Elisabeth, Tikhonova Irina G, Milligan Graeme, Zhang Cheng
Department of Pharmacology and Chemical Biology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
School of Pharmacy, Queen's University Belfast, Belfast, UK.
Nature. 2025 Jun 18. doi: 10.1038/s41586-025-09186-6.
Free fatty acid receptor 2 (FFA2) is a G protein-coupled receptor (GPCR) that is a primary sensor for short-chain fatty acids produced by gut microbiota. Consequently, FFA2 is a promising drug target for immunometabolic disorders. Here we report cryogenic electronic microscopy structures of FFA2 in complex with two G proteins and three distinct classes of positive allosteric modulators (PAMs), and describe noncanonical activation mechanisms that involve conserved structural features of class A GPCRs. Two PAMs disrupt the E/DRY activation microswitch and stabilize the conformation of intracellular loop 2 by binding to lipid-facing pockets near the cytoplasmic side of the receptor. By contrast, the third PAM promotes the separation of transmembrane helices 6 and 7 by interacting with transmembrane helix 6 at the receptor-lipid interface. Molecular dynamic simulations and mutagenesis experiments confirm these noncanonical activation mechanisms. Furthermore, we demonstrate the molecular basis for the G versus G bias, which is due to distinct conformations of intracellular loop 2 stabilized by different PAMs. These findings provide a framework for the design of tailored GPCR modulators, with implications that extend beyond FFA2 to the broader field of GPCR drug discovery.
游离脂肪酸受体2(FFA2)是一种G蛋白偶联受体(GPCR),是肠道微生物群产生的短链脂肪酸的主要传感器。因此,FFA2是免疫代谢紊乱的一个有前景的药物靶点。在此,我们报告了FFA2与两种G蛋白以及三类不同的正变构调节剂(PAM)结合的低温电子显微镜结构,并描述了涉及A类GPCR保守结构特征的非经典激活机制。两种PAM破坏E/DRY激活微开关,并通过与受体胞质侧附近面向脂质的口袋结合来稳定细胞内环2的构象。相比之下,第三种PAM通过在受体-脂质界面与跨膜螺旋6相互作用来促进跨膜螺旋6和7的分离。分子动力学模拟和诱变实验证实了这些非经典激活机制。此外,我们证明了G偏向与G偏向的分子基础,这是由于不同PAM稳定的细胞内环2的不同构象所致。这些发现为定制GPCR调节剂的设计提供了一个框架,其影响不仅限于FFA2,还扩展到更广泛的GPCR药物发现领域。